Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Tenaya Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
TNYA
Nasdaq
8731
https://www.tenayatherapeutics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Tenaya Therapeutics Inc
With 35% stake, Tenaya Therapeutics, Inc. (NASDAQ:TNYA) seems to have captured institutional investors' interest
- May 30th, 2023 1:06 pm
Wall Street Analysts Believe Tenaya Therapeutics, Inc. (TNYA) Could Rally 217.58%: Here's is How to Trade
- May 15th, 2023 1:55 pm
Tenaya Therapeutics, Inc. (TNYA) Is a Great Choice for 'Trend' Investors, Here's Why
- May 11th, 2023 12:50 pm
Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
- May 10th, 2023 8:19 pm
Tenaya Highlights Growing Capabilities in AAV Manufacturing, Capsid Engineering and Expansion into Gene Editing with Six Abstracts Accepted for Presentation at the ASGCT 26th Annual Meeting
- May 3rd, 2023 12:00 pm
We Think Tenaya Therapeutics (NASDAQ:TNYA) Needs To Drive Business Growth Carefully
- May 3rd, 2023 11:09 am
Tenaya Therapeutics Receives FDA Fast Track Designation for TN-201
- May 2nd, 2023 11:50 am
The 7 Best Biotech Stocks for Personalized Medicine Investors
- Apr 25th, 2023 10:35 am
3 Penny Stocks to Buy for 100% Returns
- Apr 23rd, 2023 8:02 pm
Tenaya Therapeutics to Participate at Chardan's 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
- Apr 21st, 2023 8:05 pm
Why This Nasdaq Stock Caught Fire This Week
- Apr 20th, 2023 6:46 pm
These 2 ‘Strong Buy’ Penny Stocks Could Rally to $40 (or More), Says Piper Sandler
- Apr 19th, 2023 3:36 pm
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
- Mar 8th, 2023 9:01 pm
Tenaya Therapeutics to Participate in Upcoming Investor Conferences
- Feb 7th, 2023 10:17 pm
Tenaya Therapeutics, Inc. (TNYA) Upgraded to Buy: Here's What You Should Know
- Jan 26th, 2023 5:00 pm
Tenaya Therapeutics Announces TN-201 IND Clearance and Anticipated 2023 Milestones
- Jan 9th, 2023 12:00 pm
Insiders who placed huge bets on Tenaya Therapeutics, Inc. (NASDAQ:TNYA) earlier this year would be disappointed with the 23% drop
- Dec 21st, 2022 11:12 am
Tenaya Therapeutics Appoints Amy Burroughs to Board of Directors
- Dec 7th, 2022 9:30 pm
Tenaya Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for its Gene Therapy for Genetic Arrhythmogenic Right Ventricular Cardiomyopathy
- Nov 28th, 2022 1:30 pm
Here's Why Tenaya Therapeutics (NASDAQ:TNYA) Must Use Its Cash Wisely
- Nov 24th, 2022 10:54 am
Scroll